News

Pharmabiz15m
Aldeyra Therapeutics gets US FDA’s special protocol assessment agreement letter for its drug candidate, ADX-2191 to treat primary vitreoretinal lymphoma
Aldeyra Therapeutics, Inc, a biotechnology company devoted to discovering innovative therapies designed to treat immune-mediated and metabolic diseases, announced the receipt of a special protocol ...
Pharmabiz1h
Bone Biologics seeks US patent for bone regeneration technology
Bone Biologics Corporation (Bone Biologics), a developer of orthobiologic products for spine fusion markets, announces the filing of a patent application with the United States Patent and Trademark ...
Pharmabiz3h
BioPorto initiates commercialization of ProNephro AKI for diagnostic use in US
BioPorto A/S, an in vitro diagnostics company, announced the initiation of commercialization in the US of ProNephro AKI (NGAL) for clinical use in risk stratification for moderate-to-severe AKI for ...
Pharmabiz7h
Sobi’s Gamifant receives US FDA approval for first-ever treatment for adults and children with MAS in Still's disease
Stockholm, Sweden Monday, June 30, 2025, 10:00 Hrs [IST] ...
Pharmabiz5h
China NMPA approves Innovent’s mazdutide, first dual GCG/GLP-1 receptor agonist for chronic weight management
China NMPA approves Innovent’s mazdutide, first dual GCG/GLP-1 receptor agonist for chronic weight management: San Francisco, US Monday, June 30, 2025, 12:00 Hrs [IST] Innovent ...
Pharmabiz6h
UCB announces phase 3 study of fenfluramine in CDKL5 deficiency disorder meets primary and key secondary endpoints
UCB announces phase 3 study of fenfluramine in CDKL5 deficiency disorder meets primary and key secondary endpoints: Brussels, Belgium Monday, June 30, 2025, 11:00 Hrs [IST] UCB, a ...
Pharmabiz6h
Torrent Pharma to acquire controlling stake in JB Chemicals & Pharmaceuticals
Torrent Pharmaceuticals has announced acquisition of a controlling stake in JB Chemicals & Pharmaceuticals Ltd from New York-based global investment firm KKR, with plans to merge the two entities ...
Pharmabiz9h
SLAs can invoke provisions of restricted license to ensure availability of pharmacists in rural areas: DCC
SLAs can invoke provisions of restricted license to ensure availability of pharmacists in rural areas: DCC: Gireesh Babu, New Delhi Monday, June 30, 2025, 08:00 Hrs [IST] The Drug ...
Pharmabiz8h
PharmaTech Expo & LabTech Expo 2025 to be held from August 5 to 7 in Gandhinagar
PharmaTech Expo & LabTech Expo 2025 to be held from August 5 to 7 in Gandhinagar: Our Bureau, Mumbai Monday, June 30, 2025, 09:00 Hrs [IST] PharmatechnologyIndex.com Pvt Ltd is pl ...
Pharmabiz9h
Telangana DCA's arrests of wholesalers for spurious drugs trigger nationwide call for stronger enforcement
Telangana DCA's arrests of wholesalers for spurious drugs trigger nationwide call for stronger enforcement: Peethaambaran Kunnathoor, Chennai Monday, June 30, 2025, 08:00 Hrs [IST ...
Pharmabiz9h
DCGI responds on clarifications sought by Pharmexcil on export NOC guidance document
DCGI responds on clarifications sought by Pharmexcil on export NOC guidance document: Shardul Nautiyal, Mumbai Monday, June 30, 2025, 08:00 Hrs [IST] In order to ensure smooth imp ...
Pharmabiz9h
Pharmexcil, USP discuss collaboration on biosimilar accessibility, building resilient supply chain
Pharmexcil, USP discuss collaboration on biosimilar accessibility, building resilient supply chain: Shardul Nautiyal, Mumbai Monday, June 30, 2025, 08:00 Hrs [IST] The Pharmaceuti ...